Sage Rhino Capital LLC Amgen Inc Transaction History

Sage Rhino Capital LLC

$439 Million
Q3 2024

A detailed history of Sage Rhino Capital LLC transactions in Amgen Inc stock. As of the latest transaction made, Sage Rhino Capital LLC holds 2,457 shares of AMGN stock, worth $723,660. This represents 0.18% of its overall portfolio holdings.

Number of Shares

2,457

Previous 2,453 0.16%

Holding current value

$723,660

Previous $766,000 3.26%

% of portfolio

0.18%

Previous 0.19%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	BUY	$309.38 - $337.38 $1,237 - $1,349	4 Added 0.16%	2,457 $791,000
Q2 2024 Jul 30, 2024	SELL	$262.75 - $319.31 $13,400 - $16,284	-51 Reduced 2.04%	2,453 $766,000
Q1 2024 Apr 26, 2024	BUY	$268.87 - $324.56 $9,141 - $11,035	34 Added 1.38%	2,504 $711,000
Q4 2023 Feb 05, 2024	SELL	$255.7 - $288.46 $767 - $865	-3 Reduced 0.12%	2,470 $711,000
Q3 2023 Oct 26, 2023	BUY	$218.65 - $271.46 $874 - $1,085	4 Added 0.16%	2,473 $664,000
Q2 2023 Jul 31, 2023	SELL	$214.27 - $253.37 $16,927 - $20,016	-79 Reduced 3.1%	2,469 $548,000
Q1 2023 Apr 20, 2023	SELL	$225.79 - $275.2 $326,266 - $397,664	-1,445 Reduced 36.19%	2,548 $615,000
Q4 2022 Jan 31, 2023	BUY	$229.03 - $291.01 $341,941 - $434,477	1,493 Added 59.72%	3,993 $1.05 Million
Q3 2022 Oct 24, 2022	SELL	$224.46 - $253.15 $6,958 - $7,847	-31 Reduced 1.22%	2,500 $564,000
Q2 2022 Jul 28, 2022	SELL	$230.71 - $256.74 $1,384 - $1,540	-6 Reduced 0.24%	2,531 $616,000
Q1 2022 Apr 27, 2022	BUY	$219.27 - $242.57 $1,754 - $1,940	8 Added 0.32%	2,537 $613,000
Q4 2021 Feb 04, 2022	BUY	$198.88 - $227.6 $8,154 - $9,331	41 Added 1.65%	2,529 $569,000
Q3 2021 Oct 18, 2021	BUY	$212.27 - $248.7 $4,882 - $5,720	23 Added 0.93%	2,488 $529,000
Q2 2021 Jul 27, 2021	BUY	$233.58 - $259.14 $3,737 - $4,146	16 Added 0.65%	2,465 $601,000
Q1 2021 May 04, 2021	BUY	$221.91 - $258.6 $28,182 - $32,842	127 Added 5.47%	2,449 $609,000
Q3 2020 Nov 05, 2020	SELL	$234.65 - $260.95 $469 - $521	-2 Reduced 0.09%	2,322 $590,000
Q2 2020 Jul 30, 2020	BUY	$197.81 - $242.74 $19,187 - $23,545	97 Added 4.36%	2,324 $548,000
Q1 2020 Apr 29, 2020	SELL	$182.24 - $241.7 $4,191 - $5,559	-23 Reduced 1.02%	2,227 $451,000
Q4 2019 Jan 31, 2020	SELL	$189.21 - $243.2 $7,000 - $8,998	-37 Reduced 1.62%	2,250 $536,000
Q3 2019 Oct 25, 2019	BUY	$174.11 - $208.62 $13,232 - $15,855	76 Added 3.44%	2,287 $443,000
Q2 2019 Aug 20, 2019	SELL	$166.7 - $195.41 $19,837 - $23,253	-119 Reduced 5.11%	2,211 $407,000
Q1 2019 Apr 18, 2019	BUY	$180.87 - $203.88 $421,427 - $475,040	2,330 New	2,330 $443,000

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sage Rhino Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sage Rhino Capital LLC with notifications on news.

Account

Sage Rhino Capital LLC Amgen Inc Transaction History